drugset / Trial / NCT00002621
Interferon Alfa in Treating Children With HIV-Related Cancer
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase II trial to study the effectiveness of interferon alfa in treating children with an HIV-related cancer including leukemia, non-Hodgkin's lymphoma, CNS lymphoma, or other solid tumors.
Timeline
- Start
- 1994-12
- Primary completion
- 2002-07
- Completion
- 2005-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | interferon alfa-2b | Protein / enzyme biologic | — | Subcutaneous |